208 studies found for:    Cerebral Atrophy
Show Display Options
Rank Status Study
21 Terminated
Has Results
Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II
Condition: Multiple Sclerosis
Interventions: Drug: Polyphenon E;   Other: Placebo
22 Recruiting Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Condition: Multiple Sclerosis
Intervention: Drug: Rituximab
23 Recruiting Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
Conditions: Atypical Alzheimers Disease;   Logopenic Variant of Primary Progressive Aphasia (LPA);   Posterior Cortical Atrophy (PCA)
Intervention: Drug: C-11 PiB
24 Completed Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b
Condition: Relapsing-remitting Multiple Sclerosis
Interventions: Drug: Interferon beta-1b group;   Drug: Interferon beta-1b/Atorvastatin group
25 Terminated Flupirtine as Oral Treatment in Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Flupirtine;   Drug: Placebo
26 Completed Does Glaucoma Cause Loss of Brain Function?
Condition: Glaucoma
Intervention:
27 Recruiting Oculomotor Testing in the Differential Diagnosis of Dementia
Conditions: Lewy Body Disease;   Alzheimer's Disease
Intervention: Other: oculomotor measurements
28 Recruiting The PACO Study ("Personnalité Alzheimer COmportement")
Condition: Alzheimer Disease
Intervention: Behavioral: questioning
29 Completed Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: intravenous injection of mesenchymal stem cells;   Biological: injection of cell free media
30 Completed Clinical Findings in General Paresis
Condition: General Paresis
Intervention:
31 Recruiting Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach
Condition: Multiple System Atrophy
Interventions: Drug: EGCG as putative neuroprotective agent;   Drug: Placebo
32 Not yet recruiting Cohort Study to Investigate the Association Between Changes in Brain Volume and Postoperative Cognitive Dysfunction
Conditions: Postoperative Cognitive Dysfunction;   Delirium;   Dementia
Intervention:
33 Unknown  Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life
Condition: Multiple Sclerosis
Intervention:
34 Active, not recruiting Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
Condition: Multiple Sclerosis, Chronic Progressive
Interventions: Drug: lipoic acid;   Drug: Placebo
35 Withdrawn Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment
Condition: Alzheimer's Disease
Interventions: Drug: CHF 5074 1x;   Drug: CHF 5074 2x;   Drug: Placebo
36 Recruiting The Microvascular Brain Retina And Kidney Study
Condition: Cerebral Small Vessels Disease
Intervention:
37 Terminated
Has Results
Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Glatiramer Acetate;   Drug: Placebo;   Drug: Prednisone
38 Not yet recruiting MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Amiloride;   Drug: Riluzole;   Drug: Ibudilast;   Drug: Placebo
39 Completed Magnetic Stimulation Therapy for Treating Vascular Depression
Conditions: Depressive Disorder;   Depression
Interventions: Procedure: Repetitive transcranial magnetic stimulation (rTMS);   Drug: Citalopram;   Procedure: Sham rTMS
40 Active, not recruiting (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy
Conditions: Cancer;   Central Nervous System Disease;   Nervous System Disease;   Peripheral Nervous System Disease;   Progressive Multifocal Leukoencephalopathy
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years